LGL. Gavrila

L. Gavrila

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L. Gavrila has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 24 August 2010
      • Vol. 105  (3) , 379-82

    MTRR polymorphism and the risk for colorectal and breast cancer in Romanian patients--a preliminary study.

    by T Burcoş, M Toma, M Stavarachi, D Cimponeriu, P Apostol, E Popa, S Stăñilescu, I Popa, I Radu, C Serafinceanu, et al.

    The risk of colorectal cancer (CRC) and breast cancer (BC) is influenced by polymorphisms located in the genes encoding enzymes of the folate pathway. The aim of this study was to evaluate if A66G MTRR (rs1801394) polymorphism is involved in predisposition for colorectal and breast carcinogenesis in Romanian patients. In the present case-control study, 300 individuals divide in four groups: sporadic CRC patients (n = 120), control CRC (n = 60), BC patients (n = 60) and control BC (n = 60), were genotyped by PCR-RFLP method. Frequency of genotype AA was 11.7% in CRC control and 5% respectively in BC control. For cancer groups the frequency of genotype AA was 9.2% in CRC and 0% in BC. Study results do not demonstrate an association between A66G MTRR polymorphism and CRC or BC in Romanian patients.


    • 1 December 2009
      • Vol. 104  (5) , 553-6

    Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients.

    by M Toma, D Cimponeriu, P Apostol, M Stavarachi, M Cojocaru, L Belusică, A M Crăciun, I Radu, L Gavrilă

    The insertion/deletion polymorphism of the angiotensin I-converting enzyme (ACE) gene has recently been linked to the pathogenesis of human cancers. The goal of this study was to analyze the possible association between ACE gene I/D polymorphism and colorectal cancer in Romanian patients. Blood samples were obtained, after informed consent, from individuals with colorectal cancer (n=108, M:W = 64:44), and healthy persons (n=150, M:W = 84:66). Genomic DNA was extracted from peripheral blood leucocytes using commercial kits and the insertion (I) / deletion (D) polymorphism was assessed by PCR. Statistical analysis was done using the chi2 test. We determined the odds ratio using the genotype II as risk factor. A p value < 0.05 was considered statistically significant. The distribution of ACE II: ID: DD genotypes was 23.1%: 46.3%: 30.6% in patients and respectively 20%: 48.7%: 31.3% in controls. The distribution of genotype (chi2 0.37, p = 0.54) and alleles (chi2 0.19, p = 0.65) did not differ significantly between cancer patients and control. Study results do not demonstrate an association between ACE ID polymorphism and colorectal cancer in our patients.


  • G.P.4.07 A preliminary study on the relationship between VDR gene polymorphisms and risk for childhood SMA disease

    by M. Stavarachi, P. Apostol, D. Cimponeriu, M. Toma, N. Butoianu, L. Gavrila

  • ANALYSIS OF THE ROLE OF MTHFR C677T AND TGF-BETA C-509T POLYMORPHISMS IN TYPE 1 DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE

    by C.I. Tecuceanu, D. Cimponeriu, P. Apostol, M. Stavarachi, M. Toma, D. Usurelu, A.M. Craciun, D. Letitia, L. Gavrila, D. Cheta

  • NMP04 Diagnosis of spinal muscular atrophies in Romania

    by N. Butoianu, P. Apostol, D. Cimponeriu, C. Iliescu, I. Minciu, C. Burloiu, D. Craiu, M. Budisteanu, R. Gherghiceanu, M. Stavarachi, et al.

  • Scanning of β‐globin gene for identification of β‐thalassemia mutation in Romanian population

    by R. Talmaci, J. Traeger‐Synodinos, E. Kanavakis, D. Coriu, D. Colita, L. Gavrila

    β‐Thalassemia is uncommon (0.5%) in the Romanian population, but it must be considered in the differential diagnosis of hypochromic anemia. The molecular characterization of β‐thalassemia is absolutely necessary for molecular diagnosis, as well as any genetic epidermiological study in this region. Molecular analyses consist of mutation detection by molecular scanning of β‐globin gene. This gene has 3 exons and 2 introns, involved in β‐thalassemic pathogenesis. Clinical application of DNA analysis on β‐thalassemic chromosomes allowed characterization of 29 persons with different β‐thalassemia mutations among 58 patients with anemia. The experimental strategy was based on sequential PCR amplification of most of the β‐globin gene and running on denaturing gradient gel electrophoresis of amplification products. Definitive characterization of mutations in samples identified with shifted DGGE patterns was performed ARMS‐PCR and/or PCR‐restriction enzyme analysis methods. Eight different β‐thalassemia alleles were identified, the most common being IVS I‐110 (G‐A) and cd 39 (C‐T). Comparison of overall frequency of mutations in the neighboring countries, shows that these results are in the frame of overall distribution of these mutations in Mediterranean area, especially in Greece and in Bulgaria. Molecular diagnosis is useful for differentiating mild from severe alleles, for genetic counseling, as well as for mutation definition in carriers, identified by hematological analysis necessary for prenatal testing and genetic counseling.


  • Scrreening for microdeletions in human Y chromosome‐AZF candidate genes and male infertility

    by Florina Raicu, L. Popa, Pompilia Apostol, D. Cimpomeriu, Letitia Dan, Elena Ilinca, Laura Luana Dracea, B. Marinescu, L. Gavrila

    About 30% of couple infertilities are of male origin, some of them caused by genetic abnormalities of the Y chromosome. Deletions in AZF region can cause severe spermatogenic defects ranging from non‐obstructive azoospermia to oligospermia. The intracytoplasmatic sperm injection technique (ICSI) is rapidly becoming a versatile procedure for human assisted reproduction in case of male infertility. The use of ICSI allows Y chromosome defects to be passed from father. The goal of our study is to evaluate the frequency of microdeletions in the long arm of Y chromosome, within the AZF regions, in these cases of infertilities, using molecular genetics techniques. Thirty infertile men with azoospermia or oligozoospermia, determined by spermogram, were studied after exclusion of patients with endocrine or obstructive causes of infertility. Peripheral blood DNA was extracted from each patient, then amplified by multiplex PCR with STS genomic markers from the Y chromosome AZF zones. Each case was checked by multiplex PCR through coamplification with the SRY marker. Three men with microdeletions of the long arm of the Y chromosome were diagnosed among the 30 patients, corresponding to a proportion of 10%. The relatively high proportion of microdeletions found in our population suggest the need for strict patient selection to avoid unnecessary screening for long arm Y chromosome microdeletions. The molecular diagnostics was performed according to the current European Academy of Andrology laboratory guidelines for molecular diagnosis of Y chromosomal microdeletions.